Koninklijke Philips (NYSE:PHG - Get Free Report) announced its earnings results on Wednesday. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01), Zacks reports. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The business had revenue of $5.38 billion for the quarter, compared to analyst estimates of $5.10 billion.
Koninklijke Philips Stock Performance
Koninklijke Philips stock traded up $0.50 during trading hours on Friday, hitting $25.53. 2,295,393 shares of the stock traded hands, compared to its average volume of 710,086. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74. The firm's 50 day moving average price is $26.25 and its 200-day moving average price is $28.14. The stock has a market capitalization of $24.00 billion, a price-to-earnings ratio of -30.40, a P/E/G ratio of 0.82 and a beta of 0.77. Koninklijke Philips has a 1 year low of $19.75 and a 1 year high of $32.91.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on PHG. StockNews.com raised Koninklijke Philips from a "hold" rating to a "buy" rating in a research report on Thursday. Jefferies Financial Group raised Koninklijke Philips from an "underperform" rating to a "hold" rating in a research report on Tuesday, October 29th. Finally, UBS Group raised Koninklijke Philips from a "neutral" rating to a "buy" rating in a research report on Thursday. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".
Read Our Latest Analysis on Koninklijke Philips
About Koninklijke Philips
(
Get Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
